Acta Naturae
Scope & Guideline
Unveiling the Complexities of Molecular Life
Introduction
Aims and Scopes
- Molecular Biology and Genetics:
The journal publishes research on molecular mechanisms, genetic variations, and gene expression regulation, with a particular emphasis on novel genetic tools and methodologies. - Biotechnology and Bioengineering:
Research articles often explore innovative applications of biotechnology, including synthetic biology, recombinant DNA technology, and the development of therapeutic agents. - Cancer Research and Therapeutics:
A significant portion of the journal's content is dedicated to cancer biology, focusing on tumor microenvironments, signaling pathways, and potential therapeutic strategies. - Immunology and Infectious Diseases:
The journal covers topics related to immune responses, vaccine development, and the mechanisms of infectious diseases, particularly in the context of emerging viral pathogens. - Cell Biology and Physiology:
Research on cellular mechanisms, including autophagy, cell signaling, and the physiological role of cells in various contexts, is a core area of focus. - Nanotechnology in Medicine:
The journal features studies on the application of nanotechnology in biomedical research, including drug delivery systems and diagnostic tools. - Neuroscience and Neurobiology:
Acta Naturae includes research on neurological disorders, neuronal signaling, and the impact of genetic factors on brain function.
Trending and Emerging
- CRISPR and Genome Editing Technologies:
There's a growing interest in CRISPR and other genome editing technologies, reflecting their transformative potential in genetics and therapeutic applications. - Personalized Medicine and Genomics:
Emerging studies focus on personalized medicine approaches, particularly in cancer treatment and genetic disorders, emphasizing the need for tailored therapeutic strategies. - Nanomedicine and Drug Delivery Systems:
Research on nanotechnology applications in medicine, especially for targeted drug delivery and enhanced diagnostic techniques, is gaining momentum. - Synthetic Biology and Bioengineering:
The rise of synthetic biology as a field is evident, with increasing publications on engineered biological systems and their applications in biotechnology. - Neurobiology of Disease:
An increased focus on the molecular and cellular mechanisms underlying neurodegenerative diseases indicates a trend towards understanding the complexities of brain health. - Immunotherapy and Cancer Vaccines:
Research is increasingly directed towards innovative immunotherapeutic approaches, including cancer vaccines and monoclonal antibodies, reflecting advancements in cancer treatment.
Declining or Waning
- Classical Pharmacology:
There has been a noticeable decrease in studies focused solely on classical pharmacological approaches, with a shift towards more integrated and innovative methodologies in drug discovery. - Basic Virology Studies:
Research strictly limited to basic virology without a translational or therapeutic angle has become less frequent, as the interest shifts towards practical applications in vaccine and antiviral development. - Traditional Genetic Mapping Techniques:
The focus on classical genetic mapping techniques has diminished, likely due to the increasing prevalence of high-throughput sequencing technologies and advanced genetic editing tools. - In vitro Models of Disease:
While still relevant, there is a decline in the number of papers utilizing traditional in vitro models of disease, as more researchers favor complex in vivo systems and organ-on-chip technologies. - Environmental and Ecological Studies:
Research focusing on environmental impacts and ecological genetics has seen a decline, possibly overshadowed by the increasing emphasis on biomedical applications.
Similar Journals
FASEB BioAdvances
Unlocking the Secrets of Life SciencesFASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.
FASEB JOURNAL
Pioneering Insights in Biochemistry, Genetics, and MedicineFASEB JOURNAL, published by Wiley, stands as a leading interdisciplinary platform in the realm of biological sciences, prominently featured in the United States. With an impressive 2023 impact factor placing it in the Q1 category across various fields including Biochemistry, Biotechnology, Genetics, Molecular Biology, and Medicine (miscellaneous), the journal is recognized for its substantial contribution to advancing knowledge and innovation. It serves as a vital resource for researchers, professionals, and students alike, providing high-quality, peer-reviewed articles that explore the molecular and cellular mechanisms underlying health and disease. The FASEB JOURNAL not only emphasizes accessible scientific communication but also fosters collaboration within these dynamic fields, making it an essential publication for anyone engaged in cutting-edge life sciences research. To explore more about the journal's offerings and access its vast repository of scholarly articles, visit their official page.
Biochemistry and Cell Biology
Illuminating pathways in biochemistry and cell biology research.Biochemistry and Cell Biology, published by Canadian Science Publishing, is a prestigious journal that has been instrumental in advancing the fields of biochemistry, molecular biology, and cell biology since its inception in 1986. With an impressive scope spanning innovative research findings to comprehensive reviews, this journal serves as a vital resource for researchers, professionals, and students alike. Currently positioned in the Q2 quartile in Biochemistry and Q3 quartiles in both Cell Biology and Molecular Biology, it reflects a robust contribution to scientific discourse, placing it among reputable publications in its field. The journal boasts notable rankings within the Scopus database, highlighting its impact and relevance, and continues to be a valuable platform for disseminating pivotal research. By providing access to a wide array of articles, the journal remains committed to fostering knowledge and collaboration in the scientific community.
JOURNAL OF BIOMEDICAL SCIENCE
Transforming discoveries into impactful biomedical advancements.JOURNAL OF BIOMEDICAL SCIENCE, published by BMC, is a premier Open Access journal dedicated to the rapid dissemination of research in the fields of biomedical science, encompassing crucial areas such as biochemistry, cell biology, clinical biochemistry, and more. Since its inception in 1993, the journal has established itself as a leading publication, currently boasting a remarkable impact factor and quality as evidenced by its Q1 quartile rankings across multiple categories in 2023. With an impressive track record, including a Scopus ranking in the top percentiles across several disciplines, it serves as a vital resource for researchers, professionals, and students who are keen on advancing their knowledge in biomedicine. The journal operates under a fully Open Access model, ensuring that all published articles are freely available to the global research community, thus contributing to the broader dissemination and accessibility of scientific knowledge. Based in the United Kingdom, JOURNAL OF BIOMEDICAL SCIENCE is committed to fostering innovation and collaboration in research, appealing to those aiming to make impactful contributions to the biomedical sphere.
Genes & Diseases
Innovating solutions through genetic research and discovery.Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.
Cell Reports
Pioneering Open Access for Tomorrow's InnovationsCell Reports is a prestigious open-access journal published by CELL PRESS that has firmly established itself as a leading voice in the fields of Biochemistry, Genetics, and Molecular Biology. Since its inception in 2012, the journal has provided an innovative platform for rapid dissemination of cutting-edge research, ensuring that high-quality findings are accessible to a global audience. With an impressive impact factor and ranking within the top 10% in its category, as reflected by its Q1 ranking in Scopus, Cell Reports serves a vital role in advancing scientific knowledge and fostering collaboration among researchers. The journal's commitment to the open-access model not only enhances visibility but also encourages the sharing of critical advancements in molecular biology. Situated in the Netherlands, its contributions are recognized worldwide, making Cell Reports an indispensable resource for scientists aiming to stay at the forefront of their fields and facilitate breakthroughs that may shape the future of biomedicine.
TURKISH JOURNAL OF BIOLOGY
Empowering Researchers with Open Access to Cutting-edge ScienceTURKISH JOURNAL OF BIOLOGY, published by the Tubitak Scientific & Technological Research Council Turkey, is an esteemed peer-reviewed periodical that serves as a pivotal platform for advancing the fields of Agricultural and Biological Sciences. With a strong focus on innovative research across various biological domains, including Cell Biology, Genetics, and Microbiology, this journal not only fulfills the academic community's quest for high-quality research but also fosters collaboration and knowledge sharing among researchers. The journal's notable impact factors reflect its commitment to excellence, with its latest rankings placing it in Q2 in Agricultural and Biological Sciences (miscellaneous) and in Q4 for several other categories. By offering open access to its content, TURKISH JOURNAL OF BIOLOGY ensures that valuable biological insights are readily available to the global academic community. Its convergence from 2006 to 2024 signifies its longstanding influence in the biosciences, making it an essential resource for researchers, professionals, and students alike aiming to stay at the forefront of biological research and innovation.
BIOCELL
Innovative Insights into Cellular MechanismsBIOCELL is a distinguished peer-reviewed journal dedicated to the field of Cell Biology, published by TECH SCIENCE PRESS. Since its inception in 1995, the journal has been at the forefront of disseminating innovative research, with converged publication years extending from 1995 to 2013 and from 2015 to 2024. Although it currently holds a Q4 ranking in the Cell Biology category according to the 2023 category quartiles, BIOCELL aims to foster advancements by providing a platform for researchers, professionals, and students to share their findings in biochemistry, genetics, and molecular biology. The journal is available in both print (ISSN: 0327-9545) and digital formats (E-ISSN: 1667-5746) and seeks to attract contributions that enhance scholarly dialogue and understandings of cellular mechanisms and innovations. With a commitment to quality research and critical discourse, BIOCELL plays an important role in nurturing the scientific community within Argentina and beyond, offering vital insights that contribute to the advancement of the life sciences.
Life Science Alliance
Bridging Gaps in Biochemistry, Ecology, and Beyond.Life Science Alliance, published by LIFE SCIENCE ALLIANCE LLC, is a premier open access journal that has been making significant contributions to the fields of Biochemistry, Genetics and Molecular Biology, Ecology, Health, Toxicology and Mutagenesis, and Plant Science since its inception in 2018. With an impressive ranking in Scopus, including Q1 quartile positions and high percentiles in relevant categories, this journal is a vital resource for researchers, professionals, and students alike who seek to advance knowledge and innovation in life sciences. The journal operates on an open access model, ensuring that research findings are freely available to the global scientific community, thereby enhancing the visibility and impact of published work. With a commitment to fostering collaboration and disseminating high-quality research, Life Science Alliance serves as an essential platform for the promotion and exchange of scientific knowledge, aiming to bridge gaps and stimulate discussions across multiple disciplines.
CELLULAR AND MOLECULAR BIOLOGY
Pioneering Discoveries in Cell BiologyCellular and Molecular Biology is a prominent academic journal published by C M B ASSOC, specializing in the dynamic fields of cellular and molecular biology. Established in 1977, this journal has consistently aimed to disseminate groundbreaking research that contributes to our understanding of biochemical processes, cell dynamics, and molecular mechanisms governing life. With its ISSN 0145-5680 and E-ISSN 1165-158X, the journal plays a vital role in the exchange of innovative ideas, evidenced by its coverage of research from 1977 to 2024. Although currently categorized in the Q4 quartile for major disciplines such as Biochemistry and Cell Biology, it is dedicated to fostering the development of the field by welcoming submissions that challenge the conventional understanding and lead to novel insights. Researchers and academics looking to contribute to or stay updated in the rapidly evolving landscape of molecular biology will find this journal a valuable resource for connecting with a global community of scientists.